nach oben

Reviews in Endocrine and Metabolic Disorders

Erschienen in:

01.06.2014

Assembly of adiponectin oligomers

verfasst von: Tsu-Shuen Tsao

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Adiponectin is among the most studied adipokines, the collection of molecules secreted from adipose tissue. It is also one of the most architecturally complex adipokines with its various oligomeric states that include trimers, hexamers, nonamers (9mers), dodecamers (12mers), and octadecamers (18mers). The importance of adiponectin in metabolic regulation is underscored by its strong positive associations with improvement in insulin action and also decreased risks for developing type 2 diabetes. Understanding the mechanisms involved in maintaining the steady-state concentrations of adiponectin oligomers in circulation is therefore likely to provide important insight into the development of insulin resistance. This review will discuss the current state of knowledge regarding the biochemical composition of adiponectin oligomers, the commonly used techniques to analyze them, and the known post-translational modifications that affect their assembly. Evidence based on in vitro oligomer assembly reactions in support of a “cystine ratchet” model of adiponectin oligomer formation will be considered along with limitations of the evidence. Secretory pathway proteins that have been shown to affect the distribution of adiponectin oligomers will also be discussed along with hypotheses regarding their potential involvement in the cystine ratchet model of adiponectin oligomerization.

Ailhaud G. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol. 2006;329(8):570–7. discussion 653–5.PubMed

Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746–9.PubMed

Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–703.PubMed

Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221(2):286–9.PubMed

Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120(4):803–12.PubMed

Tsao T-S, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002;440(2–3):213–21.PubMed

Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595–9.PubMed

Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti- inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86(8):3815–9.PubMed

Qiang L, Wang H, Farmer SR. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol. 2007;27(13):4698–707.PubMedCentralPubMed

10.

Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism. 2007;56(11):1493–9.PubMed

11.

Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88.PubMed

12.

Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33.PubMed

13.

Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8(3):264–80.PubMed

14.

Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278(11):9073–85.PubMed

15.

Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond). 2008;32 Suppl 7:S13–8.

16.

Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006;16(5):141–6.PubMedCentralPubMed

17.

Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6(1):27–35.PubMedCentralPubMed

18.

Nanayakkara G, Kariharan T, Wang L, Zhong J, Amin R. The cardio-protective signaling and mechanisms of adiponectin. Am J Cardiovasc Dis. 2012;2(4):253–66.PubMedCentralPubMed

19.

Maddineni S, Metzger S, Ocón O, Hendricks G, Ramachandran R. Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology. 2005;146(10):4250–6.PubMed

20.

Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertension. 2008;51(1):8–14.PubMed

21.

Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26(8):2442.PubMed

22.

Trujillo ME, Scherer PE. Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257(2):167–75.PubMed

23.

Wong GW, Wang J, Hug C, Tsao T-S, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A. 2004;101(28):10302–7.PubMedCentralPubMed

24.

You M, Rogers CQ. Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med (Maywood). 2009;234(8):850–9.

25.

Wang Y, Lam KSL, Yau M-H, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J. 2008;409(3):623–33.PubMed

26.

Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol. 1998;8(6):335–8.PubMed

27.

Min X, Lemon B, Tang J, Liu Q, Zhang R, Walker N, et al. Crystal structure of a single-chain trimer of human adiponectin globular domain. FEBS Lett. 2012;586(6):912–7.PubMed

28.

Tsao T-S, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 2002;277(33):29359–62.PubMed

29.

Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352–63.PubMed

30.

Koide T, Nagata K. Collagen. In: Brinckmann J, Notbohm H, Müller PK, editors. Collagen. Springer: Berlin; n.d.

31.

Hausrath AC, Goriely A. The Fourier transforms of curves and filaments and their application to low-resolution protein crystallography. J Appl Cryst. 2009;42(2):268–78.

32.

Tsao T-S, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(50):50810–7.PubMed

33.

Frizzell N, Rajesh M, Jepson MJ, Nagai R, Carson JA, Thorpe SR, et al. Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem. 2009;284(38):25772–81.PubMedCentralPubMed

34.

Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H, et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun. 2007;356(2):487–93.PubMed

35.

Mashalidis EH, Briggs DB, Zhou M, Vergara AM, Chhun JJ, Ellsworth RK, et al. High-resolution identification of human adiponectin oligomers and regulation by pioglitazone in type 2 diabetic patients. Anal Biochem. 2013;437(2):150–60.PubMed

36.

Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008;149(5):2270–82.PubMedCentralPubMed

37.

Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55(1):249–59.PubMed

38.

Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes. 2005;54(9):2712–9.PubMed

39.

Xu A, Chan KW, Hoo RLC, Wang Y, Tan KCB, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073–80.PubMed

40.

Briggs DB, Jones CM, Mashalidis EH, Nuñez M, Hausrath AC, Wysocki VH, et al. Disulfide-dependent self-assembly of adiponectin octadecamers from trimers and presence of stable octadecameric adiponectin lacking disulfide bonds in vitro. Biochemistry. 2009;48(51):12345–57.PubMedCentralPubMed

41.

Suzuki S, Wilson-Kubalek EM, Wert D, Tsao T-S, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett. 2007;581(5):809–14.PubMedCentralPubMed

42.

Niemann B, Pan R, Teschner M, Boening A, Silber R-E, Rohrbach S. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue. Exp Gerontol. 2012.

43.

Fisher FFM, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE, et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia. 2005;48(6):1084–7.PubMed

44.

Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279(13):12152–62.PubMed

45.

Abbasi F, Chang S-A, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R139–44.PubMed

46.

Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, et al. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab. 2009;297(3):E767–73.PubMedCentralPubMed

47.

Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol. 2005;153(3):409–17.PubMed

48.

Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res. 2008;78(2):376–84.PubMed

49.

Amin RH, Mathews ST, Camp HS, Ding L, Leff T. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am J Physiol Endocrinol Metab. 2010;298(1):E28–37.PubMed

50.

Ebinuma H, Miida T, Yamauchi T, Hada Y, Hara K, Kubota N, et al. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem. 2007;53(8):1541–4.PubMed

51.

Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes. 2006;55(7):1954–60.PubMed

52.

Sinha MK, Songer T, Xiao Q, Sloan JH, Wang J, Ji S, et al. Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem. 2007;53(12):2144–51.PubMed

53.

Wang Y, Lam KSL, Chan L, Chan KW, Lam JBB, Lam MC, et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem. 2006;281(24):16391–400.PubMed

54.

Peake PW, Hughes JT, Shen Y, Charlesworth JA. Glycosylation of human adiponectin affects its conformation and stability. J Mol Endocrinol. 2007;39(1):45–52.PubMed

55.

Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep. 2003;3(3):207–13.PubMed

56.

Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10(12):1384–9.PubMedCentralPubMed

57.

Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004;145(1):367–83.PubMed

58.

Halberg N, Schraw TD, Wang ZV, Kim J-Y, Yi J, Hamilton MP, et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes. 2009;58(9):1961–70.PubMedCentralPubMed

59.

Kim J-A, Nuñez M, Briggs DB, Laskowski BL, Chhun JJ, Eleid JK, et al. Extracellular conversion of adiponectin hexamers into trimers. Biosci Rep. 2012;32(6):641–52.PubMedCentralPubMed

60.

Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 2007;56(8):2174–7.PubMed

61.

O’Leary VB, Jorett AE, Marchetti CM, Gonzalez F, Phillips SA, Ciaraldi TP, et al. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am J Physiol Endocrinol Metab. 2007;293(1):E421–7.PubMed

62.

Aso Y, Yamamoto R, Suetsugu M, Matsumoto S, Wakabayashi S, Matsutomo R, et al. Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with type 2 diabetes. Diabet Med. 2007;24(9):962–8.PubMed

63.

Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149(5):307–16.PubMedCentralPubMed

64.

Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 2007;30(2):280–5.PubMed

65.

Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J. 2008;72(1):23–8.PubMed

66.

Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol. 2010;9:26.PubMedCentralPubMed

67.

Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab. 2007;92(11):4313–8.PubMed

68.

Wang AY-H, Hickman IJ, Richards AA, Whitehead JP, Prins JB, Macdonald GA. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am J Gastroenterol. 2005;100(12):2717–23.PubMed

69.

Richards AA, Colgrave ML, Zhang J, Webster J, Simpson F, Preston E, et al. Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Mol Endocrinol. 2010;24(1):229–39.PubMed

70.

Inoue T, Takemori K, Yamamoto K, Ito H. Characterization of Wistar-Kyoto rats showing hyperadiponectinemia. Life Sci. 2010;86(9–10):344–50.PubMed

71.

Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding t-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat. 2012;33(2):402–10.PubMed

72.

Williams AS, Kasahara DI, Verbout NG, Fedulov AV, Zhu M, Si H, et al. Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses in mice. PLoS One. 2012;7(7):e41088.PubMedCentralPubMed

73.

Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR. Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab. 2008;295(4):E842–50.PubMedCentralPubMed

74.

Rasouli N, Yao-Borengasser A, Miles LM, Elbein SC, Kern PA. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab. 2006;290(1):E42–6.PubMed

75.

Savu MK, Phillips SA, Oh DK, Park K, Gerlan C, Ciaraldi TP, et al. Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels. Surg Obes Relat Dis. 2009;5(2):172–80.PubMed

76.

Wang ZV, Schraw TD, Kim J-Y, Khan T, Rajala MW, Follenzi A, et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol. 2007;27(10):3716–31.PubMedCentralPubMed

77.

Liu M, Zhou L, Xu A, Lam KSL, Wetzel MD, Xiang R, et al. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A. 2008;105(47):18302–7.PubMedCentralPubMed

78.

Liu M, Xiang R, Wilk SA, Zhang N, Sloane LB, Azarnoush K, et al. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. Diabetes. 2012;61(11):2776–86.PubMedCentralPubMed

79.

Zhou L, Liu M, Zhang J, Chen H, Dong LQ, Liu F. DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. Diabetes. 2010;59(11):2809–16.PubMedCentralPubMed

80.

Radjainia M, Wang Y, Mitra AK. Structural polymorphism of oligomeric adiponectin visualized by electron microscopy. J Mol Biol. 2008;381(2):419–30.PubMed

81.

Briggs DB, Giron RM, Malinowski PR, Nunez M, Tsao T-S. Role of redox environment on the oligomerization of higher molecular weight adiponectin. BMC Biochem. 2011;12(1):24.PubMedCentralPubMed

82.

Briggs DB, Giron RM, Schnittker K, Hart MV, Park CK, Hausrath AC, et al. Zinc enhances adiponectin oligomerization to octadecamers but decreases the rate of disulfide bond formation. Biometals. 2012;25(2):469–86.PubMed

83.

Banga A, Bodles AM, Rasouli N, Ranganathan G, Kern PA, Owens RJ. Calcium is involved in formation of high molecular weight adiponectin. Metab Syndr Relat Disord. 2008;6(2):103–11.PubMedCentralPubMed

84.

Richards AA, Stephens T, Charlton HK, Jones A, Macdonald GA, Prins JB, et al. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol. 2006;20(7):1673–87.PubMed

85.

Wang Y, Xu A, Knight C, Xu LY, Cooper GJS. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem. 2002;277(22):19521–9.PubMed

86.

Wang Y, Lu G, Wong WPS, Vliegenthart JFG, Gerwig GJ, Lam KSL, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics. 2004;4(12):3933–42.PubMed

87.

Sato C, Yasukawa Z, Honda N, Matsuda T, Kitajima K. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue specific glycoprotein, adipo Q. J Biol Chem. 2001;29:29.

88.

Butler WT, Cunningham LW. Evidence for the linkage of a disaccharide to hydroxylysine in tropocollagen. J Biol Chem. 1966;241(17):3882–8.PubMed

89.

Yonemasu K, Shinkai H, Sasaki T. Comparable content of hydroxylysine-linked glycosides in subcomponents C1q of the first component of human, bovine and mouse complement. Coll Relat Res. 1981;1(4):385–90.PubMed

90.

Bann JG, Peyton DH, Bächinger HP. Sweet is stable: glycosylation stabilizes collagen. FEBS Lett. 2000;473(2):237–40.PubMed

91.

Bann JG, Bächinger HP. Glycosylation/hydroxylation-induced stabilization of the collagen triple helix. 4-trans-hydroxyproline in the Xaa position can stabilize the triple helix. J Biol Chem. 2000;275(32):24466–9.PubMed

92.

Brodsky B, Shah NK. Protein motifs. 8. The triple-helix motif in proteins. FASEB J. 1995;9(15):1537–46.PubMed

93.

Brodsky-Doyle B, Leonard KR, Reid KB. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J. 1976;159(2):279–86.PubMedCentralPubMed

94.

Cortini M, Sitia R. From antibodies to adiponectin: role of ERp44 in sizing and timing protein secretion. Diabetes Obes Metab. 2010;12 Suppl 2:39–47.PubMed

95.

Ladner JE, Parsons JF, Rife CL, Gilliland GL, Armstrong RN. Parallel evolutionary pathways for glutathione transferases: structure and mechanism of the mitochondrial class kappa enzyme rGSTK1-1. Biochemistry. 2004;43(2):352–61.PubMed

96.

Pemble SE, Wardle AF, Taylor JB. Glutathione S-transferase class Kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J. 1996;319(Pt 3):749–54.PubMedCentralPubMed

97.

Morel F, Aninat C. The glutathione transferase kappa family. Drug Metab Rev. 2011;43(2):281–91.PubMed

98.

Theodoratos A, Blackburn AC, Coggan M, Cappello J, Larter CZ, Matthaei KI, et al. The impact of glutathione transferase kappa deficiency on adiponectin multimerisation in vivo. Int J Obes (Lond). 2012;36(10):1366–9.

99.

Sevier CS, Kaiser CA. Ero1 and redox homeostasis in the endoplasmic reticulum. Biochim Biophys Acta. 2008;1783(4):549–56.PubMed

100.

Freedman RB. A non-catalytic disulphide bond regulating redox flux in the ER oxidative folding pathway. EMBO J. 2009;28(3):169–70.PubMedCentralPubMed

101.

Tsao TS, Hug C, Lodish HF. Adipokines: regulators of metabolic integration and energy metabolism. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text (3rd ed, Chapter 65, p xviii, 1540 p.). Philadelphia: Lippincott Williams & Wilkins.

102.

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–9.PubMedCentralPubMed

103.

Merksamer PI, Trusina A, Papa FR. Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell. 2008;135(5):933–47.PubMedCentralPubMed

104.

Avezov E, Cross BCS, Kaminski Schierle GS, Winters M, Harding HP, Melo EP, et al. Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox. J Cell Biol. 2013;201(2):337–49.PubMedCentralPubMed

105.

Margittai E, Sitia R. Oxidative protein folding in the secretory pathway and redox signaling across compartments and cells. Traffic. 2011;12(1):1–8.PubMed

106.

Appenzeller-Herzog C. Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum. J Cell Sci. 2011;124(6):847–55.PubMed

107.

Radjainia M, Huang B, Bai B, Schmitz M, Yang SH, Harris PWR, et al. A highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectin. FEBS J. 2012.

108.

Riera-Guardia N, Rothenbacher D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab. 2008;10(5):367–75.PubMed

109.

Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50(9):2094–9.PubMed

110.

Zeng Q, Fu L, Takekoshi K, Kawakami Y, Isobe K. Effects of short-term exercise on adiponectin and adiponectin receptor levels in rats. J Atheroscler Thromb. 2007;14(5):261–5.PubMed

111.

Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch. 2007;455(3):479–92.PubMedCentralPubMed

112.

Coughlin CC, Finck BN, Eagon JC, Halpin VJ, Magkos F, Mohammed BS, et al. Effect of marked weight loss on adiponectin gene expression and plasma concentrations. Obesity (Silver Spring). 2007;15(3):640–5.

113.

Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, et al. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes. 2004;53(6):1621–9.PubMed

114.

Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab. 2006;291(5):E1100–5.PubMed

Titel: Assembly of adiponectin oligomers
verfasst von: Tsu-Shuen Tsao
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2014
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-013-9256-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Adiponectin signaling in the liver

Metabolic function of the CTRP family of hormones

Adiponectin and energy homeostasis